Treatment of acute non-A, non-B hepatitis with interferon.
نویسندگان
چکیده
منابع مشابه
Recombinant human interferon alfa-2b treatment for acute non-A, non-B hepatitis.
To assess the safety and possible efficacy of recombinant human interferon alfa-2b in preventing the development of chronic hepatitis, 24 adults (eight men, 16 women) with acute non-A, non-B (NANB) hepatitis were recruited to a pilot study. Half of the cases were parenterally transmitted and half were community acquired. Twelve patients received 3 million units (MU) interferon three times weekl...
متن کاملTreatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report.
We treated 10 patients who had chronic non-A,non-B hepatitis with recombinant human alpha interferon in varying doses (0.5 to 5 million units) daily, every other day, or three times weekly for up to 12 months. In 8 of the 10 patients, elevated serum aminotransferase levels decreased rapidly during therapy and eventually fell into the normal or nearly normal range. In two of these patients, the ...
متن کاملAcute fulminant non-A, non-B hepatitis leading to chronic active hepatitis after treatment with cryoprecipitate.
This report describes a carrier of haemophilia A who developed fulminant non-A, non-B hepatitis after transfusion with cryoprecipitate. She survived, but developed chronic active hepatitis.
متن کاملRecombinant interferon alfa-2b treatment in chronic non-A, non-B/type C hepatitis.
In a study of 60 patients with non-A, non-B/type C (NANB/C) chronic hepatitis alanine aminotransferase (ALT) activities returned to normal after treatment with interferon alfa-2b (3 million units for six months) in 70.7% and 29.3% did not respond. The response was maintained during four to six months, follow up in 41.4% of patients. Liver biopsy specimen showed histological improvement in all p...
متن کاملRandomised controlled trial of interferon alfa (lymphoblastoid interferon) in chronic non-A non-B hepatitis.
OBJECTIVE To determine the effect of low dose interferon alfa (human lymphoblastoid interferon) on aminotransferase activities in chronic non-A non-B hepatitis. DESIGN Prospective randomised controlled parallel group study of active treatment versus no treatment carried out over 16 weeks and preceded by baseline measurements at weeks 8 and 4 and time zero. SETTING HEPATOLOGY outpatient clin...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Kanzo
سال: 1990
ISSN: 0451-4203,1881-3593
DOI: 10.2957/kanzo.31.500